Tag: Strategic Pricing

As opioid crisis rages, cost of overdose antidote spikes | WYMT

As opioid crisis rages, cost of overdose antidote spikes | WYMT

As the opioid epidemic continues to kill tens of thousands of Americans each year, the drug naloxone has proved invaluable in preventing overdose-related deaths. Yet a spike in its cost in recent years has constrained access to naloxone, potentially depriving health care professionals, emergency responders and families of a critical treatment than can save lives. […]

HHS sued over delay in drug pricing transparency regulations | Beckers Hospital Review

HHS sued over delay in drug pricing transparency regulations | Beckers Hospital Review

The American Hospital Association and six other health organizations  have sued HHS for delaying the implementation of rules that would force drug companies to be open about their pricing and punish them for overcharging participants in a federal drug discount program. Six things to know: 1. The 340B drug pricing program, enacted nearly three decades […]

Hospitals sue to require drug pricing transparency in 340B | Healthcare Dive

Hospitals sue to require drug pricing transparency in 340B | Healthcare Dive

Dive Brief: Four industry associations sued HHS for the second time over its delay in adding regulations to the 340B Drug Pricing Program that would require pricing transparency for drug manufacturers and penalties for overcharging hospitals covered under the program. Filed by the American Hospital Association, the Association of American Medical Colleges, America’s Essential Hospitals and 340B […]

Trump Eyeing ‘Disruptive’ Changes to Drug Pricing, Azar Says | Bloomberg

Trump Eyeing ‘Disruptive’ Changes to Drug Pricing, Azar Says | Bloomberg

The Trump administration is looking to make “disruptive” changes to U.S. drug pricing to bring down costs for patients, Health and Human Services Secretary Alex Azar said. “Every player in the system has their share of blame,” Azar said in an interview at Bloomberg headquarters in New York on Wednesday, adding that he’s working on […]

The New Nonprofit Pharmaceutical World: What’s Up with That? | Nonprofit Quarterly

The New Nonprofit Pharmaceutical World: What’s Up with That? | Nonprofit Quarterly

Civica Rx, a new nonprofit drug company based in Utah, is partnering with seven of the largest US hospital systems: Intermountain Healthcare, Catholic Health Initiatives, HCA Healthcare, Mayo Clinic, Providence St. Joseph Health, SSM Health, and Trinity Health. The coalition is investing in Civica’s ability to find creative solutions to tackle the devastating effects of […]

American Hospital Association suing HHS over delay in implementing drug pricing rule for 340B | Healthcare Finance News

American Hospital Association suing HHS over delay in implementing drug pricing rule for 340B | Healthcare Finance News

The American Hospital Association and America’s Essential Hospitals have joined five other 340B stakeholders in a lawsuit against the Department of Health and Human Services over its delay in implementing a final rule for drug pricing transparency that includes monetary penalties for overcharging. HHS has delayed implementation five times. Congress in 2010 gave HHS the […]

The Secret Drug Pricing System Middlemen Use to Rake in Millions | Bloomberg

The Secret Drug Pricing System Middlemen Use to Rake in Millions | Bloomberg

How Spread Pricing Works In an analysis of pharmacy and middleman markups in Medicaid plans around the country, Bloomberg found big spreads on dozens of drugs, and evidence that the spreads are growing. For many widely used generic drugs, state insurance plans are collectively paying millions of dollars in fees to private companies. CVS is […]

Rush to end drug rebates may be bad for patients, payers, and pharma | STAT

Rush to end drug rebates may be bad for patients, payers, and pharma | STAT

In a recent interview with Reuters, Azar said that the “question of rebates may very well be fundamental to the issue of how you reverse these constant incentives to higher list prices” for medicines. He believes that, because health plans and pharmacy benefit managers profit by keeping some of the rebates, they are happy to […]

There’s more to pricing than hard costs | Woodworking Network

There’s more to pricing than hard costs | Woodworking Network

Editor’s note: Years ago, James Falk shared with readers of Cabinetmaker magazine and members of the Cabinet Makers Association his pricing theories of pricing work using the term “soft variables” to describe things that often affect the cost of work but seldom are accounted for in bidding spreadsheets. Today, Falk has expanded on this concept […]

This New Non-Profit Drug Company Wants To Fix The US Healthcare Industry | IFLScience

This New Non-Profit Drug Company Wants To Fix The US Healthcare Industry | IFLScience

In a bid to combat the exorbitant, greed-driven pricing schemes of pharmaceutical companies and increase the availability of essential generic medications, seven large American hospital chains have joined forces to form a new non-profit drug company. The plans for this endeavor were first announced in January, and as of today, we now know the name, […]